• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Invivyd (IVVD)

Common Shares
Sell: $1.78|Buy: $1.80|Change: 0.43 (31.85%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Invivyd Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of monoclonal antibody (mAb) therapies for the prevention and treatment of serious viral infectious diseases. Its lead product, PEMGARDA (pemivibart), received emergency use authorization from the U.S. FDA for the pre-exposure prevention of COVID-19 in certain immunocompromised individuals. The company is also developing next-generation antibody candidates, including VYD2311 for COVID-19 and VBY329 for RSV infections, while continuing research on additional antibodies targeting other viral diseases such as measles.

Address




Website

https://www.invivyd.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Invivyd Inc Fourth Quarter Earnings Conference Call for 20262027-03-05T08:30:00
Invivyd Inc Fourth Quarter Earnings Results for 20262027-03-05T00:00:00
Invivyd Inc Annual Report for 20262027-03-05T00:00:00
Invivyd Inc Third Quarter Earnings Conference Call for 20262026-11-06T08:30:00
Invivyd Inc Third Quarter Earnings Results for 20262026-11-06T00:00:00
Invivyd Inc Second Quarter Earnings Results for 20262026-08-14T00:00:00
Invivyd Inc Annual General Meeting for 20262026-05-20T08:30:00
Invivyd Inc First Quarter Earnings Conference Call for 20262026-05-15T08:30:00
Invivyd Inc First Quarter Earnings Results for 20262026-05-15T00:00:00

Previous key dates

NameKey Date
Invivyd Inc Fourth Quarter Earnings Conference Call for 20252026-03-05T08:30:00
Invivyd Inc Fourth Quarter Earnings Result for 20252026-03-05T00:00:00
Invivyd Inc Annual Report for 20252026-03-05T00:00:00
8(th) Annual Evercore Healthcare Conference2025-12-02T14:35:00
Invivyd Inc Third Quarter Earnings Conference Call for 20252025-11-06T08:30:00
Invivyd Inc Third Quarter Earnings Results for 20252025-11-06T00:00:00
Invivyd REVOLUTION Pivotal Program Conference Call2025-10-30T08:30:00
H.C. Wainwright 27th Annual Global Investment Conference2025-09-08T12:00:00
Cantor Global Healthcare Conference 20252025-09-03T14:10:00
Invivyd Inc Second Quarter Earnings Results for 20252025-08-14T00:00:00
H.C. Wainwright 3rd Annual BioConnect Investor Conference2025-05-20T11:00:00
Invivyd Inc Annual General Meeting for 20252025-05-20T08:30:00
Invivyd Inc First Quarter Earnings Conference Call for 20252025-05-15T08:30:00
Invivyd Inc First Quarter Earnings Result for 20252025-05-15T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.